• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Is anyone making bonus on Kyprolis?

anonymous

Guest
Who made these goals? They're reduced from S1? Yeah right. Whole districts won't make any money this S? Do they want everyone to quit? Wth? Was this ZS or internal poor goal setting?
 












You better sell or Laura Brand will have you all fired! You are a commodity. She needs results because Wharton grads like her and trump are going to make Amgen great again firing every loser rep they can!
 








nobody is making goal and all the onyx reps are gone. Left with Amgen retreads and new folks who weren't selling elsewhere. 1/1/17 is layoffs and brining krypolis into the fold with the other products.
 
























Yeah former chairmans winners from last year now are under goal? Did they forget how to sell or are the goals ridiculous? What have you done for me lately? They are going to get the sales team to quit

Good you all suck anyways. The weak Amgen obu reps will leave like their underperforming onyx_kyprolis reps did. The strong Amgen reps will remain!